Alberta Cappelli

Azienda USL di Bologna

Papers

2

Total Citations

50

H-Index

2

About

Alberta Cappelli is a leading researcher in urologic oncology, with a primary focus on improving treatment outcomes for renal cancer. Her work centers on two key areas: comparing the efficacy of minimally invasive interventions for small renal masses and leveraging advanced three-dimensional imaging to enhance surgical planning. A major contribution is her propensity score-matched analysis comparing percutaneous ablation to partial nephrectomy for cT1a renal tumors, a study that has garnered 27 citations and provides critical guidance for clinicians navigating treatment trade-offs between nephron-sparing approaches. Additionally, her pioneering research on novel volumetric and morphological parameters derived from 3D virtual modeling (23 citations) has transformed how surgeons comprehend tumor anatomy, enabling more precise and personalized interventions. By integrating quantitative imaging with clinical decision-making, Cappelli’s work directly addresses the challenge of balancing oncologic control with renal function preservation. Her studies are highly cited in the urology literature, reflecting their impact on evidence-based practice. Through these contributions, Alberta Cappelli is shaping the future of minimally invasive renal cancer care, offering tools and insights that empower surgeons to achieve better outcomes for their patients.

Research Focus

Key Achievements

2
H-Index
2
Papers
50
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score‐matched analysis
27 citations · 2021
📈 Most Prolific Year: 2021 (2 Papers)
🤝 Key Collaborators: 26
🏛 Institutions: Azienda USL di Bologna

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago